Latest Equity Stake News

Fletcher Building has completed the sale of its 13.4% stake in the Pūhoi to Warkworth toll road, marking its exit from public-private partnership investments and a renewed focus on core operations.

Golden State Mining has appointed Keith Middleton as Managing Director and CEO, bringing over two decades of mining sector expertise and a strategic vision for growth. His leadership comes with a significant share-based incentive, signaling a new chapter for the exploration company.

Argent BioPharma has secured a transformative acquisition of AusCann’s core assets, bolstering its drug delivery technology and manufacturing capabilities ahead of a planned U.S. listing. The company also reported key clinical milestones and refinancing moves in its September 2025 quarterly update.

DGR Global Limited’s Q3 2025 report reveals ongoing project development, strategic equity holdings, and complex legal proceedings shaping its resource company creation model.

Botala Energy has made significant strides in developing its Serowe coal bed methane project in Botswana, securing a $1.5 million placement and government interest to address Southern Africa’s looming gas shortage.

Hartshead Resources has secured a Well Carry Agreement with RockRose Energy, reducing its equity stake while RockRose funds critical Phase C well costs. The company also seeks a two-year licence extension amid regulatory delays, maintaining a strong cash position and clear development plans.

Apollo Minerals reports encouraging exploration results from its Gabon projects, highlighting significant gold intercepts at Salanie and a substantial zinc-lead target at Kroussou, while navigating funding constraints and ongoing legal challenges in Europe.

Austral Gold’s Q3 report reveals a sharp production drop at Guanaco following a fatal accident, prompting a downward revision of 2025 output and cost hikes, while Casposo’s refurbishment signals a new growth phase.

Aumake Limited reported a near-breakeven quarter with strong cash receipts and launched a new health product brand while securing a strategic partnership to expand Australian agricultural exports to China.

Latitude 66 Ltd reported a net cash outflow of A$889,000 for Q3 2025 but strengthened its balance sheet by completing the sale of its Greater Duchess JV interest, securing A$2 million in cash and A$4 million in shares.

Deterra Royalties reported a 10% rise in quarterly revenue driven by iron ore royalties and gold offtakes, completed a US$82 million sale of non-core assets, and marked progress on the Thacker Pass lithium project amid leadership changes.

Vectus Biosystems has signed a binding agreement to sell its VB4-P5 renal fibrosis compound to Canadian biotech XORTX Therapeutics, while actively pursuing licensing opportunities for its lead drug VB0004 and others, particularly in China.